Selinexor in Combination With Ixazomib for the Treatment of Advanced Sarcoma
Phase 1
Withdrawn
- Conditions
- LiposarcomaMalignant Peripheral Nerve Sheath TumorsAlveolar Soft Part SarcomaEwing SarcomaSarcoma
- Interventions
- First Posted Date
- 2019-03-19
- Last Posted Date
- 2020-11-27
- Lead Sponsor
- Matthew Ingham
- Registration Number
- NCT03880123
- Locations
- 🇺🇸
Columbia University Medical Center, New York, New York, United States
© Copyright 2025. All Rights Reserved by MedPath